LOXL3 and hepatocellular carcinoma: During chemotherapy, LOXL3 stabilizes DHODH by activating the mitochondrial AK2-LOXL3-DHODH pathway, inhibits mitochondrial ferroptosis, and promotes chemoresistance in HCC.